Evidence map›Paper›PMID 37916988›Full record

ArticlePsycho-oncology2023

The bodily threat monitoring scale: Development and preliminary validation in adult and childhood cancer survivors.

Lauren C Heathcote, Sarah N Webster, Nele Loecher, Sheri L Spunt, Pamela Simon, Poorva Pradhan, Daelin Coutts-Bain, Louise Sharpe, Perri R Tutelman, Laura E Simons

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Psycho-oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 4 countries.

Lauren C HeathcoteHealth Psychology Section, Department of Psychology, Institute of Psychiatry Psychology and Neuroscience, King's College London, London, UK.
Sarah N WebsterDepartment of Anesthesiology, Perioperative, and Pain Medicine, Stanford University School of Medicine, Stanford, California, USA.ORCID 0000-0001-9366-2852
Nele LoecherDepartment of Psychology and Behavioral Sciences, St Jude's Children's Research Hospital, Memphis, Tennessee, USA.
Sheri L SpuntDepartment of Pediatric Oncology, Stanford University School of Medicine, Stanford, California, USA.
Pamela SimonDepartment of Pediatric Oncology, Stanford University School of Medicine, Stanford, California, USA.
Poorva PradhanThe School of Psychology, University of Sydney, Sydney, New South Wales, Australia.
Daelin Coutts-BainThe School of Psychology, University of Sydney, Sydney, New South Wales, Australia.
Louise SharpeThe School of Psychology, University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0002-8790-6272
Perri R TutelmanDepartment of Psychology and Neuroscience, Dalhousie University, Halifax, Nova Scotia, Canada.
Laura E SimonsDepartment of Anesthesiology, Perioperative, and Pain Medicine, Stanford University School of Medicine, Stanford, California, USA.
Stanford Medicine · USThe University of Sydney · AUDalhousie University · CAKing's College London · GBSt. Jude Children's Research Hospital · US

Funding

Mentoring and Research in Biobehavioral Aspects of Pediatric PainK24AR078945 · NIAMS · STANFORD UNIVERSITY · PI LAURA E SIMONS · 2022 to 2026
$970k
NIAMS NIH HHS K24 AR078945
6 · The paper itself

Abstract

objectiveBodily threat monitoring is a core clinical feature of Fear of cancer recurrence (FCR) and is targeted in psycho-oncology treatments, yet no comprehensive self-report measure exists. The aim of this study was the theory-informed development and initial validation of the Bodily Threat Monitoring Scale (BTMS).

methodsAdult survivors of breast and gynaecological cancers (Study 1: N = 306, age = 37-81 years) and childhood cancer survivors (Study 2: N = 126, age = 10-25 years) completed the BTMS, designed to assess how individuals monitor for and interpret uncertain symptoms as indicating that something is wrong with their body. Participants completed measures to assess construct and criterion validity of the BTMS, and childhood cancer survivors (Study 2) completed the BTMS again 2 weeks later to assess test-retest reliability.

resultsThe 19-item BTMS demonstrated excellent internal consistency across adult and childhood cancer samples (α = 0.90-0.96). Factor analyses indicated two subscales capturing 1. Monitoring of bodily sensations and 2. Threatening interpretations of bodily sensations. Two-week stability estimates were acceptable. For construct validity, the BTMS correlated with body vigilance and anxiety sensitivity. The BTMS also demonstrated criterion validity, yielding significant associations with FCR, intolerance of uncertainty, help-seeking behaviours, and quality of life. The BTMS was associated with FCR while controlling for body vigilance and anxiety sensitivity, indicating a unique contribution of this theory-informed measure.

conclusionsThe BTMS shows evidence of sound psychometric properties and could be used to elucidate the role of bodily threat monitoring in the maintenance and management of FCR.

Indexed as

Cancer SurvivorsAdolescentAdultAgedAged, 80 and overChildFemaleHumansMiddle AgedNeoplasm Recurrence, LocalPhobic DisordersQuality of LifeReproducibility of ResultsSurveys and QuestionnairesYoung Adultbodily threat monitoringcancer survivorsfear of cancer recurrenceintolerance of uncertainty

Identifiers

PMID37916988
PMCPMC11311963
OpenAlexW4388233801

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.